[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novavax Inc (NVAX)

Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,501,319
  • Shares Outstanding, K 164,438
  • Annual Sales, $ 1,123 M
  • Annual Income, $ 440,300 K
  • EBIT $ -78 M
  • EBITDA $ -51 M
  • 60-Month Beta 2.45
  • Price/Sales 1.39
  • Price/Cash Flow 2.60
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 86.27% (+9.84%)
  • Historical Volatility 77.60%
  • IV Percentile 66%
  • IV Rank 16.41%
  • IV High 257.13% on 01/28/26
  • IV Low 52.73% on 06/30/25
  • Expected Move (DTE 4) 0.79 (8.66%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 6,503
  • Volume Avg (30-Day) 10,348
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 246,139
  • Open Int (30-Day) 241,159
  • Expected Range 8.34 to 9.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.36
  • Number of Estimates 4
  • High Estimate $-0.28
  • Low Estimate $-0.42
  • Prior Year $0.62
  • Growth Rate Est. (year over year) -158.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.35 +9.34%
on 06/09/26
11.61 -21.36%
on 05/27/26
+0.20 (+2.24%)
since 05/18/26
3-Month
7.57 +20.69%
on 04/02/26
11.61 -21.36%
on 05/27/26
-0.88 (-8.79%)
since 03/18/26
52-Week
6.13 +48.94%
on 06/23/25
11.97 -23.73%
on 02/26/26
+2.83 (+44.92%)
since 06/18/25

Most Recent Stories

More News
A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack

NVAX : 9.13 (-3.89%)
3 Cash-Burning Stocks We Think Twice About

3 Cash-Burning Stocks We Think Twice About

IHRT : 3.59 (-4.01%)
NVAX : 9.13 (-3.89%)
FLNC : 24.80 (+5.89%)
Novavax to Participate in 2026 Jefferies Global Healthcare Conference

GAITHERSBURG, Md. , June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

NVAX : 9.13 (-3.89%)
Why Novavax (NVAX) Stock Is Trading Up Today

Why Novavax (NVAX) Stock Is Trading Up Today

NVAX : 9.13 (-3.89%)
3 Reasons NVAX is Risky and 1 Stock to Buy Instead

3 Reasons NVAX is Risky and 1 Stock to Buy Instead

NVAX : 9.13 (-3.89%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

PTON : 5.77 (+4.34%)
NVAX : 9.13 (-3.89%)
BKV : 24.55 (+1.74%)
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

GDRX : 2.66 (+1.92%)
NVAX : 9.13 (-3.89%)
MTD : 1,144.84 (+1.36%)
RDNT : 53.74 (+1.74%)
ADUS : 94.23 (+0.38%)
The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call

The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call

NVAX : 9.13 (-3.89%)
Novavax Stock Is Red Hot but the Smart Money Is Slamming on the Brakes

Although a better-than-expected Q1 earnings print has NVAX stock skyrocketing recently, there’s a high risk in chasing this biotech play.

NVAX : 9.13 (-3.89%)
Why Novavax (NVAX) Stock Is Trading Up Today

Why Novavax (NVAX) Stock Is Trading Up Today

NVAX : 9.13 (-3.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple...

See More

Key Turning Points

3rd Resistance Point 10.63
2nd Resistance Point 10.31
1st Resistance Point 9.72
Last Price 9.13
1st Support Level 8.81
2nd Support Level 8.49
3rd Support Level 7.90

See More

52-Week High 11.97
Fibonacci 61.8% 9.74
Last Price 9.13
Fibonacci 50% 9.05
Fibonacci 38.2% 8.36
52-Week Low 6.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.